Related Experiment Video

Updated: Jun 30, 2025

Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

54.9K

Updated criteria for paediatric sepsis and septic shock

Priya Venkatesan

    The Lancet. Infectious Diseases
    |March 23, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
    14:54

    A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

    Published on: January 27, 2019

    11.0K
    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
    07:30

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

    Published on: June 15, 2019

    10.0K

    Related Experiment Videos

    Last Updated: Jun 30, 2025

    Cecal Ligation Puncture Procedure
    11:53

    Cecal Ligation Puncture Procedure

    Published on: May 7, 2011

    54.9K
    A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
    14:54

    A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

    Published on: January 27, 2019

    11.0K
    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
    07:30

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

    Published on: June 15, 2019

    10.0K

    Related Concept Videos

    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    324
    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    324

    Articles linked to this work by shared authors, journal, and citation graph.

    Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.

    The Lancet. Infectious diseases·2026

    Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.

    The Lancet. Infectious diseases·2026

    Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trial.

    The Lancet. Infectious diseases·2026

    Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study.

    The Lancet. Infectious diseases·2026

    Congenital tuberculosis presenting as acute cervical lymphadenitis in a 28-week preterm infant.

    The Lancet. Infectious diseases·2026

    Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial.

    The Lancet. Infectious diseases·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us